Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OSIS | CLS |
|---|---|---|
| Price | $197.87 | $382.69 |
| Change today | ▲ 0.55% | ▼ 1.20% |
| Market cap | $3.15B | $47.71B |
| Return, 3 months | -9.5% | +10.9% |
| Return, year to date | -22.4% | +29.5% |
| Return, 1 year | -21.2% | +62.6% |
| P/E (TTM) | 22.1 | 39.8 |
| P/B | 3.8 | 19.2 |
| P/E percentile vs own 5y | – | 78th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +62.4% |
| Net profit growth (YoY) | – | +74.8% |
| Gross margin | – | 12.0% |
| Operating margin | – | 8.8% |
| Net margin | – | 7.2% |
| Return on equity | – | 52.7% |
| Analyst target vs. price | +40.4% | +20.6% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 43 | 63 |
| 30-day volatility | 22.9% | 62.5% |
| Max drawdown, 1 year | -37.9% | -41.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
